{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:30:05Z","timestamp":1789986605753,"version":"4.0.1"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","award":["9803212295"],"award-info":[{"award-number":["9803212295"]}],"id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015027","name":"Vice Chancellor for Research and Technology, Hamadan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.biopha.2022.112670","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T20:31:56Z","timestamp":1643833916000},"page":"112670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Prevention, inhibition, and degradation effects of melittin alone and in combination with vancomycin and rifampin against strong biofilm producer strains of methicillin-resistant Staphylococcus epidermidis"],"prefix":"10.1016","volume":"147","author":[{"given":"Rasoul","family":"Mirzaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Yousef","family":"Alikhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Renata","family":"Arciola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Sedighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Yousefimashouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran Pooshang","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2022.112670_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrmicro2182","article-title":"Staphylococcus epidermidis--the 'accidental' pathogen","volume":"7","author":"Otto","year":"2009","journal-title":"Nature reviews. Microbiology"},{"key":"10.1016\/j.biopha.2022.112670_bib2","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3389\/fmicb.2017.01401","article-title":"Pathogenic mechanisms and host interactions in Staphylococcus epidermidis device-related infection","volume":"8","author":"Sabat\u00e9 Bresc\u00f3","year":"2017","journal-title":"Frontiers in microbiology"},{"issue":"8","key":"10.1016\/j.biopha.2022.112670_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrmicro2182","article-title":"Staphylococcus epidermidis\u2014the'accidental'pathogen","volume":"7","author":"Otto","year":"2009","journal-title":"Nature reviews microbiology"},{"key":"10.1016\/j.biopha.2022.112670_bib4","first-page":"1","article-title":"The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19)","author":"Mirzaei","year":"2021","journal-title":"Archives of Virology"},{"issue":"3","key":"10.1016\/j.biopha.2022.112670_bib5","article-title":"The human immune system against Staphylococcus epidermidis","volume":"39","author":"Rasoul","year":"2019","journal-title":"Critical Reviews\u2122 in Immunology"},{"issue":"12","key":"10.1016\/j.biopha.2022.112670_bib6","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1211\/jpp.60.12.0001","article-title":"Staphylococcus epidermidis device-related infections: pathogenesis and clinical management, The","volume":"60","author":"McCann","year":"2008","journal-title":"Journal of pharmacy and pharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2022.112670_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/IPC.0000000000000437","article-title":"Prevalence of atlE, ica, mecA, and mupA Genes in Staphylococcus epidermidis Isolates","volume":"25","author":"Mirzaei","year":"2017","journal-title":"Infectious Diseases in Clinical Practice"},{"issue":"26","key":"10.1016\/j.biopha.2022.112670_bib8","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1016\/j.biomaterials.2012.05.031","article-title":"Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials","volume":"33","author":"Arciola","year":"2012","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.biopha.2022.112670_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/MRM.0000000000000216","article-title":"The host metabolism following bacterial biofilm: what is the mechanism of action?","volume":"31","author":"Mirzaei","year":"2020","journal-title":"Reviews in Medical Microbiology"},{"issue":"7","key":"10.1016\/j.biopha.2022.112670_bib10","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/iub.2266","article-title":"The biofilm\u2010associated bacterial infections unrelated to indwelling devices","volume":"72","author":"Mirzaei","year":"2020","journal-title":"IUBMB life"},{"key":"10.1016\/j.biopha.2022.112670_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104393","article-title":"The importance of intracellular bacterial biofilm in infectious diseases","author":"Mirzaei","year":"2020","journal-title":"Microbial Pathogenesis"},{"issue":"6","key":"10.1016\/j.biopha.2022.112670_bib12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2217\/fmb.10.56","article-title":"Current concepts in biofilm formation of Staphylococcus epidermidis","volume":"5","author":"Fey","year":"2010","journal-title":"Future microbiology"},{"issue":"12","key":"10.1016\/j.biopha.2022.112670_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e01067","article-title":"Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention","volume":"4","author":"Khatoon","year":"2018","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.biopha.2022.112670_bib14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3390\/ijms17060992","article-title":"Molecular characteristics of methicillin-resistant Staphylococcus epidermidis on the abdominal skin of females before laparotomy","volume":"17","author":"Wang","year":"2016","journal-title":"International journal of molecular sciences"},{"issue":"10","key":"10.1016\/j.biopha.2022.112670_bib15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/s41564-018-0230-7","article-title":"Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis","volume":"3","author":"Lee","year":"2018","journal-title":"Nature microbiology"},{"issue":"6","key":"10.1016\/j.biopha.2022.112670_bib16","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/JCM.06456-11","article-title":"A multidrug-resistant Staphylococcus epidermidis clone (ST2) is an ongoing cause of hospital-acquired infection in a Western Australian hospital","volume":"50","author":"Widerstr\u00f6m","year":"2012","journal-title":"Journal of Clinical Microbiology"},{"issue":"2","key":"10.1016\/j.biopha.2022.112670_bib17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/JCM.40.2.430-438.2002","article-title":"Molecular characterization of methicillin-resistant Staphylococcus epidermidis clones: evidence of geographic dissemination","volume":"40","author":"Miragaia","year":"2002","journal-title":"Journal of Clinical Microbiology"},{"issue":"1","key":"10.1016\/j.biopha.2022.112670_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1128\/JCM.37.1.39-44.1999","article-title":"Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy","volume":"37","author":"Sieradzki","year":"1999","journal-title":"Journal of clinical microbiology"},{"issue":"4","key":"10.1016\/j.biopha.2022.112670_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijantimicag.2005.11.013","article-title":"Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening","volume":"27","author":"Nunes","year":"2006","journal-title":"International journal of antimicrobial agents"},{"issue":"7","key":"10.1016\/j.biopha.2022.112670_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/pharmaceutics11070322","article-title":"Biofilms: Novel Strategies Based on Antimicrobial Peptides","volume":"11","author":"Galdiero","year":"2019","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.biopha.2022.112670_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-021-02707-w","article-title":"Challenges of antibiotic resistance biofilms and potential combating strategies: a review","volume":"11","author":"Khan","year":"2021","journal-title":"3 Biotech"},{"issue":"12","key":"10.1016\/j.biopha.2022.112670_bib22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrmicro.2017.99","article-title":"Targeting microbial biofilms: current and prospective therapeutic strategies","volume":"15","author":"Koo","year":"2017","journal-title":"Nature Reviews Microbiology"},{"issue":"2","key":"10.1016\/j.biopha.2022.112670_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/mdr.2018.0016","article-title":"Highly synergistic effects of melittin with conventional antibiotics against multidrug-resistant isolates of acinetobacter baumannii and pseudomonas aeruginosa","volume":"25","author":"Akbari","year":"2019","journal-title":"Microbial Drug Resistance"},{"issue":"3","key":"10.1016\/j.biopha.2022.112670_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10096-018-3189-7","article-title":"Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii","volume":"37","author":"Bardbari","year":"2018","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"12","key":"10.1016\/j.biopha.2022.112670_bib25","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.3390\/ma11122468","article-title":"Action of antimicrobial peptides against bacterial biofilms","volume":"11","author":"Yasir","year":"2018","journal-title":"Materials"},{"key":"10.1016\/j.biopha.2022.112670_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.661195","article-title":"Antimicrobial Peptides Derived From Insects Offer a Novel Therapeutic Option to Combat Biofilm: A Review","volume":"12","author":"Sahoo","year":"2021","journal-title":"Frontiers in Microbiology"},{"issue":"3","key":"10.1016\/j.biopha.2022.112670_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.it.2008.12.003","article-title":"AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense","volume":"30","author":"Lai","year":"2009","journal-title":"Trends in immunology"},{"issue":"287","key":"10.1016\/j.biopha.2022.112670_bib28","article-title":"Review: Lessons Learned From Clinical Trials Using Antimicrobial","volume":"12","author":"Dijksteel","year":"2021","journal-title":"Peptides (AMPs), Frontiers in Microbiology"},{"issue":"5","key":"10.1016\/j.biopha.2022.112670_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/pep2.24122","article-title":"Antimicrobial peptides under clinical investigation","volume":"111","author":"Koo","year":"2019","journal-title":"Peptide Science"},{"issue":"2","key":"10.1016\/j.biopha.2022.112670_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00399424","article-title":"Applications of the bacteriocin, nisin","volume":"69","author":"Delves-Broughton","year":"1996","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"2","key":"10.1016\/j.biopha.2022.112670_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1084\/jem.2032fta","article-title":"Ren\u00e9 Dubos: unearthing antibiotics, The","volume":"203","author":"Van Epps","year":"2006","journal-title":"Journal of experimental medicine"},{"issue":"12","key":"10.1016\/j.biopha.2022.112670_bib32","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/ph6121543","article-title":"Antimicrobial peptides","volume":"6","author":"Bahar","year":"2013","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.biopha.2022.112670_bib33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/apm.12791","article-title":"Membrane\u2010active peptide PV 3 efficiently eradicates multidrug\u2010resistant Pseudomonas aeruginosa in a mouse model of burn infection","volume":"126","author":"Memariani","year":"2018","journal-title":"Apmis"},{"issue":"1","key":"10.1016\/j.biopha.2022.112670_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/cbdd.13381","article-title":"The activity and action mechanism of novel short selective LL\u201037\u2010derived anticancer peptides against clinical isolates of Escherichia coli","volume":"93","author":"Aghazadeh","year":"2019","journal-title":"Chemical biology & drug design"},{"key":"10.1016\/j.biopha.2022.112670_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.matchemphys.2021.124432","article-title":"Melittin antimicrobial peptide thin layer on bone implant chitosan-antibiotic coatings and their bactericidal properties","volume":"263","author":"Zarghami","year":"2021","journal-title":"Materials Chemistry and Physics"},{"key":"10.1016\/j.biopha.2022.112670_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2021.05.015","article-title":"Eradication of vancomycin-resistant Staphylococcus aureus on a mouse model of third-degree burn infection by melittin: an antimicrobial peptide from bee venom","author":"Bevalian","year":"2021","journal-title":"Toxicon"},{"issue":"2409","key":"10.1016\/j.biopha.2022.112670_bib37","article-title":"Combination Strategies to Enhance the Efficacy of Antimicrobial Peptides against Bacterial Biofilms","volume":"8","author":"Grassi","year":"2017","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/j.biopha.2022.112670_bib38","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3389\/fmicb.2017.02409","article-title":"Combination strategies to enhance the efficacy of antimicrobial peptides against bacterial biofilms","volume":"8","author":"Grassi","year":"2017","journal-title":"Frontiers in microbiology"},{"issue":"6","key":"10.1016\/j.biopha.2022.112670_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007084","article-title":"Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens","volume":"14","author":"Pletzer","year":"2018","journal-title":"PLoS pathogens"},{"issue":"8","key":"10.1016\/j.biopha.2022.112670_bib40","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1007\/s00253-019-09698-y","article-title":"Melittin: from honeybees to superbugs","volume":"103","author":"Memariani","year":"2019","journal-title":"Applied microbiology and biotechnology"},{"key":"10.1016\/j.biopha.2022.112670_bib41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.micpath.2018.11.055","article-title":"Single dose eradication of extensively drug resistant Acinetobacter spp. in a mouse model of burn infection by melittin antimicrobial peptide","volume":"127","author":"Pashaei","year":"2019","journal-title":"Microbial pathogenesis"},{"issue":"2","key":"10.1016\/j.biopha.2022.112670_bib42","first-page":"108","article-title":"Induction of IFN-\u03b3 cytokine response against hepatitis B surface antigen using melittin","volume":"7","author":"Dezfuli","year":"2014","journal-title":"Gastroenterology and hepatology from bed to bench"},{"issue":"1","key":"10.1016\/j.biopha.2022.112670_bib43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10989-018-9675-z","article-title":"Kinetics study of antimicrobial peptide, melittin, in simultaneous biofilm degradation and eradication of potent biofilm producing MDR Pseudomonas aeruginosa isolates","volume":"25","author":"Khozani","year":"2019","journal-title":"International Journal of Peptide Research and Therapeutics"},{"issue":"5","key":"10.1016\/j.biopha.2022.112670_bib44","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/cbdd.12702","article-title":"A new, high yield, rapid, and cost\u2010effective protocol to deprotection of cysteine\u2010rich conopeptide, omega\u2010conotoxin MVIIA","volume":"87","author":"Eisapoor","year":"2016","journal-title":"Chemical biology & drug design"},{"key":"10.1016\/j.biopha.2022.112670_bib45","first-page":"14","article-title":"Structural basis of Staphylococcus epidermidis biofilm formation: mechanisms and molecular interactions","volume":"5","author":"B\u00fcttner","year":"2015","journal-title":"Frontiers in cellular and infection microbiology"},{"issue":"9","key":"10.1016\/j.biopha.2022.112670_bib46","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1167\/iovs.11-9114","article-title":"Biofilm-forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from ocular infections","volume":"53","author":"Hou","year":"2012","journal-title":"Investigative ophthalmology & visual science"},{"issue":"7","key":"10.1016\/j.biopha.2022.112670_bib47","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1167\/iovs.05-1172","article-title":"Biofilm formation by Staphylococcus epidermidis on intraocular lens material","volume":"47","author":"Okajima","year":"2006","journal-title":"Investigative ophthalmology & visual science"},{"key":"10.1016\/j.biopha.2022.112670_bib48","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.micpath.2017.04.039","article-title":"Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates","volume":"108","author":"Bardbari","year":"2017","journal-title":"Microbial pathogenesis"},{"issue":"3","key":"10.1016\/j.biopha.2022.112670_bib49","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1128\/AAC.02473-13","article-title":"Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains","volume":"58","author":"Gopal","year":"2014","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"10.1016\/j.biopha.2022.112670_bib50","article-title":"The visualisation of interactions between Acinetobacter baumannii and the antimicrobial peptides: colistin sulphate, bicarinalin and BP100","author":"Eales","year":"2015","journal-title":"University of Lincoln"},{"issue":"2","key":"10.1016\/j.biopha.2022.112670_bib51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0924-8579(00)00149-7","article-title":"Comparison of methods for assessing synergic antibiotic interactions","volume":"15","author":"Mackay","year":"2000","journal-title":"International journal of antimicrobial agents"},{"issue":"7","key":"10.1016\/j.biopha.2022.112670_bib52","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1099\/jmm.0.009209-0","article-title":"Biofilm characteristics of Staphylococcus epidermidis isolates associated with device-related meningitis","volume":"58","author":"Stevens","year":"2009","journal-title":"Journal of medical microbiology"},{"issue":"3","key":"10.1016\/j.biopha.2022.112670_bib53","first-page":"71","article-title":"An improvement of the 2\u02c6(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis","volume":"3","author":"Rao","year":"2013","journal-title":"Biostat Bioinforma Biomath"},{"issue":"4","key":"10.1016\/j.biopha.2022.112670_bib54","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10989-017-9641-1","article-title":"Apoptotic effect of melittin purified from Iranian honey bee venom on human cervical cancer HeLa cell line","volume":"24","author":"Zarrinnahad","year":"2018","journal-title":"International journal of peptide research and therapeutics"},{"issue":"13","key":"10.1016\/j.biopha.2022.112670_bib55","doi-asserted-by":"crossref","first-page":"12316","DOI":"10.1074\/jbc.M413406200","article-title":"Rational design of \u03b1-helical antimicrobial peptides with enhanced activities and specificity\/therapeutic index","volume":"280","author":"Chen","year":"2005","journal-title":"Journal of biological chemistry"},{"issue":"4","key":"10.1016\/j.biopha.2022.112670_bib56","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","article-title":"Antibiotic resistance of bacterial biofilms","volume":"35","author":"H\u00f8iby","year":"2010","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"2","key":"10.1016\/j.biopha.2022.112670_bib57","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40121-017-0153-2","article-title":"Minocycline for the treatment of multidrug and extensively drug-resistant A. baumannii: a review","volume":"6","author":"Lashinsky","year":"2017","journal-title":"Infectious diseases and therapy"},{"key":"10.1016\/j.biopha.2022.112670_bib58","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3389\/fmicb.2016.00483","article-title":"Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii","volume":"7","author":"Qi","year":"2016","journal-title":"Frontiers in microbiology"},{"key":"10.1016\/j.biopha.2022.112670_bib59","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2147\/IDR.S204432","article-title":"Association between biofilm formation, structure and antibiotic resistance in Staphylococcus epidermidis isolated from neonatal septicemia in southwest Iran","volume":"12","author":"Sheikh","year":"2019","journal-title":"Infection and drug resistance"},{"issue":"4","key":"10.1016\/j.biopha.2022.112670_bib60","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/antibiotics9040178","article-title":"Pan-Drug Resistant Acinetobacter baumannii, but Not Other Strains, Are Resistant to the Bee Venom Peptide Melittin","volume":"9","author":"Rangel","year":"2020","journal-title":"Antibiotics"},{"issue":"10","key":"10.1016\/j.biopha.2022.112670_bib61","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrd4000","article-title":"Applying insights from biofilm biology to drug development\u2014can a new approach be developed?","volume":"12","author":"Bjarnsholt","year":"2013","journal-title":"Nature reviews Drug discovery"},{"issue":"6","key":"10.1016\/j.biopha.2022.112670_bib62","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1586\/14787210.5.6.951","article-title":"Alternative mechanisms of action of cationic antimicrobial peptides on bacteria","volume":"5","author":"Hale","year":"2007","journal-title":"Expert Review of Anti-infective Therapy"},{"issue":"3","key":"10.1016\/j.biopha.2022.112670_bib63","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/cbdd.12864","article-title":"Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B","volume":"89","author":"Memariani","year":"2017","journal-title":"Chemical Biology & Drug Design"},{"issue":"1","key":"10.1016\/j.biopha.2022.112670_bib64","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ddr.21456","article-title":"Harnessing snake venom phospholipases A2 to novel approaches for overcoming antibiotic resistance","volume":"80","author":"Almeida","year":"2019","journal-title":"Drug Development Research"},{"issue":"4","key":"10.1016\/j.biopha.2022.112670_bib65","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3390\/biom10040652","article-title":"Antimicrobial and antibiofilm peptides","volume":"10","author":"Di Somma","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.biopha.2022.112670_bib66","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1179\/1973947815Y.0000000004","article-title":"Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria","volume":"28","author":"Dosler","year":"2016","journal-title":"Journal of Chemotherapy"},{"key":"10.1016\/j.biopha.2022.112670_bib67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.micpath.2017.09.046","article-title":"Melittin and its potential in the destruction and inhibition of the biofilm formation by Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa isolated from bovine milk","volume":"112","author":"Picoli","year":"2017","journal-title":"Microbial Pathogenesis"},{"issue":"11","key":"10.1016\/j.biopha.2022.112670_bib68","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1007\/s00253-016-7400-4","article-title":"Antimicrobial peptide melittin against Xanthomonas oryzae pv. oryzae, the bacterial leaf blight pathogen in rice","volume":"100","author":"Shi","year":"2016","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"3","key":"10.1016\/j.biopha.2022.112670_bib69","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1179\/1973947812Y.0000000007","article-title":"In vitro activities of antimicrobial cationic peptides; melittin and nisin, alone or in combination with antibiotics against Gram-positive bacteria","volume":"24","author":"Dosler","year":"2012","journal-title":"Journal of Chemotherapy"},{"key":"10.1016\/j.biopha.2022.112670_bib70","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/j.jcot.2019.10.002","article-title":"Effects of powdered rifampin and vancomycin solutions on biofilm production of staphylococcus aureus on orthopedic implants","volume":"11","author":"Douthit","year":"2020","journal-title":"Journal of clinical orthopaedics and trauma"},{"issue":"4","key":"10.1016\/j.biopha.2022.112670_bib71","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijantimicag.2014.11.011","article-title":"Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro","volume":"45","author":"Claessens","year":"2015","journal-title":"International journal of antimicrobial agents"},{"issue":"1","key":"10.1016\/j.biopha.2022.112670_bib72","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40121-014-0055-5","article-title":"Evaluation of high-dose daptomycin versus vancomycin alone or combined with clarithromycin or rifampin against Staphylococcus aureus and S. epidermidis in a novel in vitro PK\/PD model of bacterial biofilm","volume":"4","author":"Snyder","year":"2015","journal-title":"Infectious diseases and therapy"},{"issue":"5","key":"10.1016\/j.biopha.2022.112670_bib73","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/jac\/dkv496","article-title":"New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection","volume":"71","author":"Revest","year":"2016","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1016\/j.biopha.2022.112670_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-016-0737-0","article-title":"Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections","volume":"16","author":"Mottola","year":"2016","journal-title":"BMC microbiology"},{"issue":"1","key":"10.1016\/j.biopha.2022.112670_bib75","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13049-019-0596-4","article-title":"Sepsis: mechanisms of bacterial injury to the patient","volume":"27","author":"Minasyan","year":"2019","journal-title":"Scandinavian journal of trauma, resuscitation and emergency medicine"},{"issue":"4","key":"10.1016\/j.biopha.2022.112670_bib76","first-page":"320","volume":"10","author":"Sligl","year":"2006"},{"issue":"4","key":"10.1016\/j.biopha.2022.112670_bib77","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1128\/CMR.15.4.527-544.2002","article-title":"Acute septic arthritis","volume":"15","author":"Shirtliff","year":"2002","journal-title":"Clinical microbiology reviews"},{"key":"10.1016\/j.biopha.2022.112670_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.643335","article-title":"Anti-Biofilm approach in Infective Endocarditis exposes new treatment strategies for improved outcome","volume":"9","author":"Lerche","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.biopha.2022.112670_bib79","article-title":"Staphylococcus Epidermidis","author":"Lee","year":"2020","journal-title":"StatPearls [Internet]"},{"key":"10.1016\/j.biopha.2022.112670_bib80","first-page":"2468","article-title":"Action of Antimicrobial Peptides against Bacterial Biofilms","volume":"11","author":"Yasir","year":"2018"},{"key":"10.1016\/j.biopha.2022.112670_bib81","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fcimb.2015.00007","article-title":"Polysaccharide intercellular adhesin in biofilm: structural and regulatory aspects","volume":"5","author":"Arciola","year":"2015","journal-title":"Frontiers in cellular and infection microbiology"},{"key":"10.1016\/j.biopha.2022.112670_bib82","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3389\/fmicb.2017.02409","article-title":"Combination Strategies to Enhance the Efficacy of Antimicrobial Peptides against Bacterial Biofilms","volume":"8","author":"Grassi","year":"2017","journal-title":"Frontiers in microbiology"},{"issue":"3","key":"10.1016\/j.biopha.2022.112670_bib83","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1128\/AAC.46.3.900-903.2002","article-title":"Penetration of rifampin through Staphylococcus epidermidis biofilms","volume":"46","author":"Zheng","year":"2002","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"10.1016\/j.biopha.2022.112670_bib84","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1017\/S1479050503001042","article-title":"Growth limitation of Staphylococcus epidermidis in biofilms contributes to rifampin tolerance","volume":"1","author":"Zheng","year":"2004","journal-title":"Biofilms"},{"issue":"2","key":"10.1016\/j.biopha.2022.112670_bib85","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","article-title":"Biofilms: survival mechanisms of clinically relevant microorganisms","volume":"15","author":"Donlan","year":"2002","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.biopha.2022.112670_bib86","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","article-title":"Antibiotic resistance of bacterial biofilms","volume":"35","author":"H\u00f8iby","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.biopha.2022.112670_bib87","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.addr.2014.10.027","article-title":"Therapeutic strategies to combat antibiotic resistance","volume":"78","author":"Brooks","year":"2014","journal-title":"Advanced drug delivery reviews"},{"issue":"2","key":"10.1016\/j.biopha.2022.112670_bib88","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijantimicag.2018.10.002","article-title":"Synergistic microbicidal effect of cationic antimicrobial peptides and teicoplanin against planktonic and biofilm-encased Staphylococcus aureus","volume":"53","author":"Koppen","year":"2019","journal-title":"International journal of antimicrobial agents"},{"issue":"7","key":"10.1016\/j.biopha.2022.112670_bib89","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.bbamem.2019.05.008","article-title":"Synergistic and antibiofilm activity of the antimicrobial peptide P5 against carbapenem-resistant Pseudomonas aeruginosa","volume":"1861","author":"Martinez","year":"2019","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"issue":"3","key":"10.1016\/j.biopha.2022.112670_bib90","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clinical microbiology reviews"},{"key":"10.1016\/j.biopha.2022.112670_bib91","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","article-title":"Multi-target therapeutics: when the whole is greater than the sum of the parts","author":"Zimmermann","year":"2007","journal-title":"Drug discovery today 12(1-2)"},{"issue":"6","key":"10.1016\/j.biopha.2022.112670_bib92","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nchembio.559","article-title":"Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy","volume":"7","author":"Ejim","year":"2011","journal-title":"Nature chemical biology"},{"issue":"6","key":"10.1016\/j.biopha.2022.112670_bib93","first-page":"1183","article-title":"Monotherapy versus combination therapy, Medical","volume":"90","author":"Patel","year":"2006","journal-title":"Clinics"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:50:23Z","timestamp":1760100623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222000580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":93,"alternative-id":["S0753332222000580"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112670","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention, inhibition, and degradation effects of melittin alone and in combination with vancomycin and rifampin against strong biofilm producer strains of methicillin-resistant Staphylococcus epidermidis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112670"}}